Body and Mind Reports Record Financial Results
Body and Mind reported a record revenue of $7.16 million for Q3 FY2021, marking a 580% increase year-over-year. The quarterly net operating income rose by 268% to $0.71 million, while net loss improved to $0.25 million. The company achieved a positive adjusted EBITDA of $1.54 million. Operational expansions in California, Nevada, Ohio, and Arkansas are expected to drive revenue growth. The earnings call is scheduled for June 23, 2021.
- Q3 FY2021 revenue increased by 580% year-over-year to $7.16 million.
- Net operating income rose by 268% to $0.71 million.
- Gross profit increased to $4.27 million, up over 55% from Q2 FY2021.
- Positive adjusted EBITDA of $1.54 million, a 133% improvement from Q2 FY2021.
- Cash flow positive for the latest quarter, indicating operational efficiency.
- Net loss of $0.25 million, though improved from $1.15 million in Q2 FY2021.
Management to host earnings call June 23, after market open
VANCOUVER, BC, June 22, 2021 /PRNewswire/ - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operator, is pleased to report its financial results for the third fiscal quarter ended April 30, 2021. Financial results are reported in accordance with U.S. generally accepted accounting principles ("GAAP") and all currency is in U.S. dollars.
Q3 FY2021 Financial Summary:
- Reported Q3 FY2021 revenue of
$7.16 million , a13% increase over Q2 FY2021 ($6.32 million ), and a580% increase over Q3 FY2020 ($1.05 million ); - Gross profit of
$4.27 million , an increase in excess of55% over Q2 FY2021 ($2.74 million ); - Net Operating Income of
$0.71 million , an increase of268% over Q2 FY2021 ($0.19 million ); - Net Loss of
$ 0.25 million , an improvement of$0.90 million over Q2 FY2021 ($1.15 million net loss) - Positive Adjusted EBITDA of
$1.54 million *, an improvement of133% over Q2 FY2021 ($0.66 million ); - Cash used in operating activities was
$0.02 million for the nine months ended April 30, 2021 compared to$0.11 million for the six month period ended April 30, 2021, which indicates the Company was cash flow positive for the three month period ended April 30, 2021 - Inventory of
$3.52 million as of April 30, 2021; - At April 30, 2021, BaM had
$1.32 million in cash and a working capital surplus of$1.96 million ; - Total Assets were
$42.21 million and Total Liabilities were$9.41 million at April 30, 2021; - 109,077,778 common shares were issued and outstanding as of April 30, 2021 (109,077,778 as of June 21, 2021).
Operational Milestones for nine month period ending April 30, 2021 and to Date:
California:
- ShowGrow Long Beach dispensary ownership transferred to
100% owned Body and Mind subsidiary to allow consolidation of revenues effective August 28, 2020; - ShowGrow San Diego dispensary has commenced delivery service in addition to curbside pickup and other on-line ordering purchase options;
- The Company has executed a lease and received local approval for a cannabis manufacturing and distribution facility in California.
Nevada:
- Received cannabis distribution license from the state of Nevada;
- Body and Mind branded products sold through almost all dispensaries throughout Las Vegas and Nevada;
- Completed expansion of new cultivation space and new flower rooms are in use providing an increase in cultivation output by approximately
20% ; - Worked with brand partner Her Highness to launch their female-focused brand into the Las Vegas market.
Ohio:
- NMG Ohio production facility construction complete and State operational approvals received;
- Ownership of The Clubhouse dispensary outside Cleveland, Ohio transferred to a
100% owned Body and Mind subsidiary to allow consolidation of revenues effective September 4, 2020; - Rebranded the dispensary as Body and Mind in September 2020;
- Commenced curbside and online express order purchasing options.
Arkansas:
- Cultivation commenced with first plant batches in vegetative stage;
- Body and Mind dispensary awarded "Best Dispensary in Arkansas" by Ark420.com;
- Commenced delivery and online ordering purchase options;
- The facility construction Capex is complete with approximately 3,500 square feet of retail and approximately 6,500 square feet constructed for future cultivation and packaging operations.
"The continued growth across all of our markets is reflected in our record quarterly results and clean balance sheet as our operations continue to increase revenue, gross profit and EBITDA across our cultivation, production and dispensary platforms," stated Michael Mills, CEO of BaM. "In addition to growing revenues this quarter, our team has commenced cultivation in Arkansas and completed construction of the Ohio production facility. Both of these opportunities are expected to add revenue this fiscal year and allow expansion of Body and Mind branded offerings to new markets. Our development team is working on our California manufacturing and distribution opportunity and our licensing team continues to advance applications at state and local levels in our current states as well as applications in new states. Our team continues to actively review potential acquisitions and other opportunities to continue our growth and expansion."
*Adjusted EBITDA is a Non-GAAP metric used by management that does not have any standardized meaning prescribed by U.S. GAAP and may not be comparable to similar measures presented by other companies. Management defines the Adjusted EBITDA as the Income (loss) from operations, as reported, before interest, taxes, and adjusted for removing other non-cash items, including the stock-based compensation expense, depreciation, and further adjustments to remove acquisition related costs or gains. Management believes Adjusted EBITDA is a useful financial metric to assess its operating performance on a cash adjusted basis before the impact of non-cash items and acquisition activities. The most comparable financial measure calculated and presented in accordance with U.S. GAAP is net operating income (loss), which was presented above prior to the Adjusted EBITDA figure.
The unaudited consolidated interim financial statements for the quarter ended April 30, 2021 are available on SEDAR and EDGAR and should be read in connection with this news release.
The Company will be hosting earnings call on Wednesday, June 23nd, 2021 at 10:30 a.m. Eastern.
Participants can dial 1-888-664-6392 or 416-764-8659 and use confirmation number 03306817 .
A replay of the conference call will be available at 1-888-390-0541 until June 30, 2021. Please use replay number 306817 #
View the Body and Mind video at:
https://www.youtube.com/watch?v=x4Kv0IspqnY&list=PLpvtfnO6zJVIINtW_tLr3aeIuOpYqJmUR&index=3
About Body and Mind Inc.
BaM is an operations focused multi-state operator investing in high quality medical and recreational cannabis cultivation, production and retail. Our wholly owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licenses and holds cultivation and production licenses. BaM products include dried flower, edibles, oils and extracts as well as GPEN Gio cartridges. BaM cannabis strains have won numerous awards including the 2019 Las Vegas Weekly Bud Bracket, Las Vegas Hempfest Cup 2016, High Times Top Ten, the NorCal Secret Cup and the Emerald Cup.
BaM continues to expand operations in Nevada, California, Arkansas and Ohio and is dedicated to increasing shareholder value by focusing time and resources on improving operational efficiencies, facility expansions, state licensing opportunities as well as mergers and acquisitions.
Please visit www.bodyandmind.com for more information.
Instagram:@bodyandmindBaM
Twitter: @bodyandmindBaM
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for the statements of historical fact contained herein, the information presented in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans, "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and should be viewed as "forward-looking statements". Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the actual results of activities, variations in the underlying assumptions associated with the estimation of activities, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labor disputes and other risks. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.
Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.
View original content:http://www.prnewswire.com/news-releases/body-and-mind-reports-record-financial-results-301317336.html
SOURCE Body and Mind Inc.
FAQ
What are Body and Mind's Q3 FY2021 financial results?
When is Body and Mind's earnings call?
What is the adjusted EBITDA for Body and Mind in Q3 FY2021?
How did Body and Mind perform in terms of net operating income for Q3 FY2021?
What operational milestones has Body and Mind achieved recently?
